Skip to main content

Table 1 Demographic and biochemical data of epileptic children at baseline and post-AED treatmenta

From: Potential effects of valproate and oxcarbazepine on growth velocity and bone metabolism in epileptic children- a medical center experience

Baseline
Overall gender (N)  
 Male/Female 40/33
 Total 73
Age (yrs) 9.8 ± 4.1
Type of AEDs (N)  
 Valproate 23
 Oxcarbazepine 29
 Valproate + Oxcarbazepine 21
Growth evaluation  
 Height (cm) 133.5 ± 21.5
 Height-SDS -0.2 ± 1.3
 Weight (kg) 35.0 ± 17.0
 Weight-SDS 0.5 ± 1.8
 Body mass index-SDS 1.1 ± 2.6
Laboratory studies  
 Aspartate aminotransferase (U/L) 27.6 ± 7.5
 Alanine aminotransferase(U/L) 17.1 ± 7.8
 Blood urea nitrogen (mg/dL) 13.0 ± 1.2
 Creatinine (mg/dL) 0.5 ± 0.2
 Alkaline phosphatase (U/L) 226.8 ± 85.0
 Total calcium (mg/dL) 9.5 ± 0.4
 Free calcium (mg/dL) 4.9 ± 0.3
 Phosphorous (mg/dL) 4.7 ± 0.3
 Hemoglobin (g/dL) 13.0 ± 1.2
Post-treatment
Laboratory studies  
 Serum TRAcP5b (umol/L/min) 4.8 ± 1.7
 TRAcP5b-SDS -1.6 ± 1.2
 Serum BAP (umol/L/min) 144.4 ± 73.2
 BAP-SDS 1.7 ± 3.7
 Total calcium (mg/dL) 9.2 ± 0.3
 Free calcium (mg/dL) 4.7 ± 0.3
  1. aData presented as mean ± SD